Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Receivables (2016 - 2025)

Historic Receivables for BioRestorative Therapies (BRTX) over the last 11 years, with Q3 2025 value amounting to $13400.0.

  • BioRestorative Therapies' Receivables fell 9187.88% to $13400.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13400.0, marking a year-over-year decrease of 9187.88%. This contributed to the annual value of $188400.0 for FY2024, which is 87616.58% up from last year.
  • According to the latest figures from Q3 2025, BioRestorative Therapies' Receivables is $13400.0, which was down 9187.88% from $15000.0 recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Receivables ranged from a high of $188400.0 in Q4 2024 and a low of $5000.0 during Q4 2021
  • For the 5-year period, BioRestorative Therapies' Receivables averaged around $37252.6, with its median value being $18000.0 (2021).
  • Its Receivables has fluctuated over the past 5 years, first soared by 87616.58% in 2024, then crashed by 9187.88% in 2025.
  • Over the past 5 years, BioRestorative Therapies' Receivables (Quarter) stood at $5000.0 in 2021, then soared by 220.0% to $16000.0 in 2022, then rose by 20.62% to $19300.0 in 2023, then skyrocketed by 876.17% to $188400.0 in 2024, then crashed by 92.89% to $13400.0 in 2025.
  • Its Receivables was $13400.0 in Q3 2025, compared to $15000.0 in Q2 2025 and $25000.0 in Q1 2025.